Friday, 14 Feb 2020

You are here

Bariatric Weight Loss Fails to Alter RA Risk

Obesity has been shown to be a risk factor for the onset of rheumatoid arthritis (RA) and also shown to affect outcomes by impairing responses to many DMARD therapies. A Swiss study of RA patients undergoing bariatric surgery failed to show that bariatric surgery and weight loss had any effect on the incidence of RA. 

The study examined patients in the Swedish Obese Subjects (SOS) study, which included 2002 obese patients who underwent bariatric surgery and 2034 matched controls.  While none had RA at baseline, there were 92 incident cases of RA.

Bariatric surgery did not alter the cohort risk of incident RA by 2 different analyses (Intent to treat: HR 0.92; 95% CI 0.59, 1.46, P = 0.74; per-protocol HR 0.86; 95% CI 0.54, 1.38, P = 0.53).  The bariatric surgery group lost considerable weight that was sustained (−17% BMI at 10 years) compared to +1.7% BMI for controls.

Similarly weight changes at the 2 year follow-up failed to predict the development of RA.

Risk factors for future RA included higher CRP levels and smoking.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Alcohols Net Zero Effect in Rheumatoid Arthritis

A report from The National Databank for Rheumatic Disease addressed the impact of alcohol on disease activity and mortality in rheumatoid arthritis (RA) and found that alcohol use was not associated with changes in disease activity or mortality, after addressing confounders. 

DMARD Inertia by Registry Rheumatologists

A registry study of metric use (primarily RAPID3 and CDAI) in the treatment of rheumatoid arthritis (RA) patients shows that, even in the face of moderate or high disease activity, treatment changes by rheumatologists were relatively low (35.6–54.6%).

Limited Advantage to Very Early vs. Delayed Etanercept in RA

The VEDERA study sought to confirm whether the very early introduction of first-line etanercept+methotrexate (ETN+MTX) was superior to treat-to-target MTX (MTX-TT) in patients with early RA.

RheumNow Podcast- 2019 EULAR RA Guidelines (1.31.20)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Rheumatoid Arthritis Antibodies Linked With COPD

Women who were seropositive for anti-citrullinated protein antibodies (ACPA) and ultimately went on to develop rheumatoid arthritis (RA) were also at increased risk for being diagnosed with chronic obstructive pulmonary disease (COPD), analysis of data from the Nurses' Health Study showed.